Zhao Wu

1.0k total citations · 1 hit paper
38 papers, 638 citations indexed

About

Zhao Wu is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Zhao Wu has authored 38 papers receiving a total of 638 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 9 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Zhao Wu's work include CAR-T cell therapy research (16 papers), MicroRNA in disease regulation (4 papers) and Pregnancy and preeclampsia studies (3 papers). Zhao Wu is often cited by papers focused on CAR-T cell therapy research (16 papers), MicroRNA in disease regulation (4 papers) and Pregnancy and preeclampsia studies (3 papers). Zhao Wu collaborates with scholars based in China, United States and Australia. Zhao Wu's co-authors include Xiao Ma, Qichao Hu, Wenwen Zhang, Shizhang Wei, Zhihao Li, Xi Peng, Yanling Zhao, Xue Peng, Longxuan Li and Xin Tian and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Zhao Wu

36 papers receiving 629 citations

Hit Papers

Baicalin and the liver-gut system: Pharmacological bases ... 2021 2026 2022 2024 2021 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Baicalin and the liver-gut system: Pharmacological bases explaining its therapeutic effects
    2021 171 citations Qichao Hu, Wenwen Zhang et al. Pharmacological Research profile →

Peers

Zhao Wu
Yuhong Sun China
Quanbao Zhang China
Xiaoming Huang China
Man Xu China
Xiaodong Peng China
Shan Zhao China
Xuemei Fan China
Lianjie Lin China
Heran Wang China
Yuhong Sun China
Zhao Wu
Citations per year, relative to Zhao Wu Zhao Wu (= 1×) peers Yuhong Sun

Countries citing papers authored by Zhao Wu

Since Specialization
Citations

This map shows the geographic impact of Zhao Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhao Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhao Wu more than expected).

Fields of papers citing papers by Zhao Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhao Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhao Wu. The network helps show where Zhao Wu may publish in the future.

Co-authorship network of co-authors of Zhao Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhao Wu. A scholar is included among the top collaborators of Zhao Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhao Wu. Zhao Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Ming, Li Ma, Zhao Wu, et al.. (2025). Early clinical predictors of fulminant myocarditis in pediatric patients: a retrospective cohort study. Frontiers in Cardiovascular Medicine. 12. 1678220–1678220.
2.
3.
Li, Xiaodong, et al.. (2024). Hesperidin inhibits colon cancer progression by downregulating SLC5A1 to suppress EGFR phosphorylation. Journal of Cancer. 16(3). 876–887. 6 indexed citations
4.
Liu, Zhenhua, Ze Chen, Zhao Wu, et al.. (2024). Associations between folate intake and knee pain, inflammation mediators and comorbid conditions in patients with symptomatic knee osteoarthritis. BMC Musculoskeletal Disorders. 25(1). 973–973. 1 indexed citations
5.
Wu, Zhao, et al.. (2024). Increased Rab1a accelerates osteoarthritis by inhibiting autophagy via activation of the mTORC1-S6K pathway. Journal of Advanced Research. 75. 607–619. 2 indexed citations
6.
Chen, Naifei, Chengfei Pu, Lingling Zhao, et al.. (2023). A phase 1 dose escalation study of GCC19CART: A novel coupled CAR therapy for patients with metastatic colorectal cancer.. Journal of Clinical Oncology. 41(16_suppl). 3547–3547. 1 indexed citations
7.
Wu, Zhao, et al.. (2022). The Small-Molecule compound baicalein alleviates experimental autoimmune encephalomyelitis by suppressing pathogenetic CXCR6+ CD4 cells. International Immunopharmacology. 114. 109562–109562. 11 indexed citations
8.
Zhang, Fangling, Xiaolin Xiao, Zhao Wu, et al.. (2021). Tripterygium hypoglaucum (Lévl.) Hutch and Its Main Bioactive Components: Recent Advances in Pharmacological Activity, Pharmacokinetics and Potential Toxicity. Frontiers in Pharmacology. 12. 715359–715359. 36 indexed citations
9.
Hu, Qichao, Wenwen Zhang, Zhao Wu, et al.. (2021). Baicalin and the liver-gut system: Pharmacological bases explaining its therapeutic effects. Pharmacological Research. 165. 105444–105444. 171 indexed citations breakdown →
10.
Zhao, Xiaolan, et al.. (2021). Up-regulation of microRNA-135 or silencing of PCSK6 attenuates inflammatory response in preeclampsia by restricting NLRP3 inflammasome. Molecular Medicine. 27(1). 82–82. 19 indexed citations
11.
Zhao, Xiaolan, et al.. (2021). Predictive value of 4-Hydroxyglutamate and miR-149-5p on eclampsia. Experimental and Molecular Pathology. 119. 104618–104618. 6 indexed citations
12.
Shan, Nan, et al.. (2021). Extracellular vesicle‐derived microRNA‐18b ameliorates preeclampsia by enhancing trophoblast proliferation and migration via Notch2/TIM3/mTORC1 axis. Journal of Cellular and Molecular Medicine. 25(10). 4583–4595. 23 indexed citations
13.
Wu, Zhao, Jinke Li, Yi Zhang, Lina Hu, & Xue Peng. (2020). <p>CFTR Regulates the Proliferation, Migration and Invasion of Cervical Cancer Cells by Inhibiting the NF-κB Signalling Pathway</p>. Cancer Management and Research. Volume 12. 4685–4697. 14 indexed citations
14.
Wu, Zhao, Bingyu Zou, Xun Zhang, & Xue Peng. (2020). Eupatilin regulates proliferation and cell cycle of cervical cancer by regulating hedgehog signalling pathway. Cell Biochemistry and Function. 38(4). 428–435. 24 indexed citations
15.
Rao, Meng, Huawei Wang, Shuhua Zhao, et al.. (2019). Subclinical Hypothyroidism Is Associated with Lower Ovarian Reserve in Women Aged 35 Years or Older. Thyroid. 30(1). 95–105. 37 indexed citations
16.
Wei, Guoqing, Yongxian Hu, Chengfei Pu, et al.. (2018). CD19 targeted CAR-T therapy versus chemotherapy in re-induction treatment of refractory/relapsed acute lymphoblastic leukemia: results of a case-controlled study. Annals of Hematology. 97(5). 781–789. 21 indexed citations
17.
Hu, Yongxian, Chengfei Pu, Haofei Zhang, et al.. (2017). Successful chimeric Ag receptor modified T cell therapy for isolated testicular relapse after hematopoietic cell transplantation in an acute lymphoblastic leukemia patient. Bone Marrow Transplantation. 52(7). 1065–1067. 7 indexed citations
18.
19.
Xue, Peng, Zhao Wu, Lei Yu, et al.. (2012). Overexpression of cystic fibrosis transmembrane conductance regulator (CFTR) is associated with human cervical cancer malignancy, progression and prognosis. Gynecologic Oncology. 125(2). 470–476. 44 indexed citations
20.
Wu, Zhao, et al.. (2000). Identification and Functional Expression of Four Isoforms of ATPase II, the Putative Aminophospholipid Translocase. Journal of Biological Chemistry. 275(30). 23378–23386. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuhong Sun Breakdown of academic impact, for papers by Quanbao Zhang Breakdown of academic impact, for papers by Xiaoming Huang Breakdown of academic impact, for papers by Man Xu Breakdown of academic impact, for papers by Xiaodong Peng Breakdown of academic impact, for papers by Shan Zhao Breakdown of academic impact, for papers by Xuemei Fan Breakdown of academic impact, for papers by Lianjie Lin Breakdown of academic impact, for papers by Heran Wang
Rankless by CCL
2026